Press Releases

Enters the US Market Pinnacle Life Science, a Subsidiary of Aarti Drugs Ltd, Enters the US Market with FDA Approval Hindustan Times September 16, 2026 Leading the Business Leaders and enterprises shaping the future of business Forbes India September 13, 2026 More Women are Joining INDIA INC More Women Are Joining India Inc Yet Few Reach The Top Business World September 12, 2026 Partnership Announcement Adcan Pharma Partners with Pinnacle Life Science Adcan Pharma September 11, 2026 Oncology Unit Inspection Support Pinnacle Life Science’s Formulations (Oncology) unit completes USFDA inspection Business Standard August 26, 2026 Building FDA Approved Plant What It Takes to Build an FDA-Approved Oncology Plant in India PTI August 20, 2026 Rising Cancer Treatment Costs The Hidden Cost Of Cancer In India And How We Can Change It BW Healthcare May 18, 2026 In Conversation - Vishwa Savla A Conversation With Vishwa Savla, CEO & Managing Director of Pinnacle Lifescience Sugermint April 20, 2026 In Conversation - Richie Gandhi Pinnacle Life Science VP Richie Gandhi on Scaling Specialized Healthcare Solutions Sugermint April 12, 2026 Women’s investment behaviour growth How women are expanding their role in India’s investment landscape CNBC TV 18 March 6, 2026 Role of preventive screening World Cancer Day: How much insurance is enough for cancer treatment? CNBC TV 18 February 4, 2026 UK MHRA CGMP Approval Pinnacle Life Science, a Subsidiary of Aarti Drugs Ltd, Expands Further with UK MHRA GMP Compliance 2 Republic January 21, 2026 UK MHRA CGMP Approval Pinnacle Life Science, a Subsidiary of Aarti Drugs Ltd, Expands Further with UK MHRA GMP Compliance Mid Day January 16, 2026 Rising medical costs in India Rising medical costs in India: Why healthcare must be central to financial planning CNBC TV 18 September 29, 2025